Simtra BioPharma Solutions News and Resources

CDMO News

Simtra BioPharma Invests $14M to Expand ADC Manufacturing Capabilities

Simtra BioPharma Solutions, a contract development and manufacturing organisation (CDMO) specialising in sterile injectables, has announced a $14 million investment aimed at expanding its clinical-scale conjugation and purification services for Antibody-Drug Conjugates (ADCs). The investment is part of Simtra’s broader

Read More »
CDMO News

Simtra BioPharma Solutions Invests $250M in Sterile Fill/Finish Site

Simtra BioPharma Solutions, a injectable contract development and manufacturing organisation (CDMO), has announced a $250+ million expansion of its sterile fill/finish manufacturing campus in Bloomington, Indiana.  A new, state-of-the-art 150,000 square foot building will be constructed to house two high-speed

Read More »
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.